Cigna (CI) to Release Earnings on Friday

Cigna (NYSE:CIGet Rating) will be posting its quarterly earnings results before the market opens on Friday, May 6th. Analysts expect Cigna to post earnings of $5.13 per share for the quarter. Cigna has set its FY22 guidance at at least $22.40 EPS.Individual interested in participating in the company’s earnings conference call can do so using this link.

Cigna (NYSE:CIGet Rating) last posted its quarterly earnings data on Thursday, February 3rd. The health services provider reported $4.77 earnings per share for the quarter, beating the Zacks’ consensus estimate of $4.68 by $0.09. Cigna had a net margin of 3.08% and a return on equity of 14.59%. The business had revenue of $45.69 billion for the quarter, compared to analysts’ expectations of $43.98 billion. During the same quarter in the previous year, the business posted $3.51 earnings per share. The business’s revenue was up 9.5% compared to the same quarter last year. On average, analysts expect Cigna to post $23 EPS for the current fiscal year and $25 EPS for the next fiscal year.

CI stock opened at $254.24 on Friday. The stock has a market capitalization of $80.94 billion, a price-to-earnings ratio of 16.15, a price-to-earnings-growth ratio of 1.06 and a beta of 0.86. Cigna has a twelve month low of $191.74 and a twelve month high of $272.81. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.66. The firm’s fifty day simple moving average is $243.93 and its two-hundred day simple moving average is $228.80.

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 23rd. Stockholders of record on Wednesday, June 8th will be paid a dividend of $1.12 per share. This represents a $4.48 dividend on an annualized basis and a dividend yield of 1.76%. Cigna’s dividend payout ratio is currently 28.46%.

A number of analysts recently weighed in on the stock. Wells Fargo & Company raised shares of Cigna from an “equal weight” rating to an “overweight” rating and upped their price objective for the stock from $236.00 to $278.00 in a research note on Thursday, January 6th. Deutsche Bank Aktiengesellschaft lowered shares of Cigna from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $271.00 to $236.00 in a research note on Friday, February 4th. Mizuho boosted their target price on shares of Cigna from $245.00 to $266.00 and gave the stock a “buy” rating in a report on Wednesday, March 2nd. Morgan Stanley reduced their target price on shares of Cigna from $238.00 to $235.00 and set an “equal weight” rating for the company in a report on Thursday, February 10th. Finally, StockNews.com assumed coverage on shares of Cigna in a report on Thursday, March 31st. They issued a “strong-buy” rating for the company. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of $261.35.

In related news, EVP Everett Neville sold 268 shares of the business’s stock in a transaction dated Monday, February 28th. The shares were sold at an average price of $228.70, for a total transaction of $61,291.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO David Cordani sold 45,380 shares of the company’s stock in a transaction dated Wednesday, April 20th. The stock was sold at an average price of $268.10, for a total transaction of $12,166,378.00. Following the completion of the transaction, the chief executive officer now owns 152,750 shares of the company’s stock, valued at approximately $40,952,275. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 91,836 shares of company stock valued at $23,795,261. Company insiders own 0.80% of the company’s stock.

Several large investors have recently modified their holdings of the company. Zullo Investment Group Inc. acquired a new stake in Cigna during the fourth quarter valued at approximately $68,000. EverSource Wealth Advisors LLC acquired a new stake in shares of Cigna during the fourth quarter valued at approximately $106,000. Sequoia Financial Advisors LLC acquired a new stake in shares of Cigna during the fourth quarter valued at approximately $216,000. Cypress Capital Group acquired a new position in Cigna in the 4th quarter valued at approximately $237,000. Finally, NEXT Financial Group Inc increased its stake in Cigna by 108.3% in the 4th quarter. NEXT Financial Group Inc now owns 1,204 shares of the health services provider’s stock valued at $276,000 after buying an additional 626 shares during the period. 86.39% of the stock is owned by institutional investors.

Cigna Company Profile (Get Rating)

Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers.

See Also

Earnings History for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.